Tacro-structure (Tacro Stucture)
Tacrolimus Capsule
Product Images NDC 67877-280
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 67877-280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tacro 05mg 100s 1
Tacro 1mg 100s 1
Each capsule of this medicine contains 1mg Tacrolimus to be used as per the dosage instructions given in the package insert. The capsules are not filled to their maximum capacity but only contain a labeled amount of Tacrolimus. Make sure to store the medicine tightly closed and away from moisture at a controlled room temperature of 20°C to 25°C (68°F to 77°F) but excursions are permitted to 15°C to 30°C (59°F to 86°F). This medicine meets USP Organic Impurities Procedure Number 2 and has been manufactured by Alkem Laboratories Ltd. It comes in a pack of 100 capsules and is distributed by Ascend Laboratories.*
Tacro 5mg 100s 1
Each capsule of Ascend Laboratories' Tacrolimus, USP contains 5 mg of tacrolimus, and is not filled to maximum capsule capacity. The capsule should be protected from moisture, stored at 20°C to 25°C (68°F to 77°F) with excursions between 15°C to 30°C (59°F to 86°F) permitted. The dosage information can be found in the package insert, and the medication meets the USP Organic Impurities Procedure Number 2. This medication is distributed by Ascend Laboratories and manufactured by Em Laboralories Ltd, Alkem (DA). The NDC number is 67877-280-01, and the medication is available in a 100 capsule size.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
